Goldman Sachs Group set a €21.00 ($24.42) price target on Evonik Industries (FRA:EVK) in a research note released on Tuesday, Borsen Zeitung reports. The brokerage currently has a sell rating on the stock.
Several other equities research analysts have also commented on the stock. Berenberg Bank set a €29.00 ($33.72) price target on shares of Evonik Industries and gave the company a buy rating in a report on Tuesday, August 6th. Sanford C. Bernstein set a €31.00 ($36.05) price objective on shares of Evonik Industries and gave the stock a buy rating in a research report on Thursday, August 1st. DZ Bank reiterated a buy rating on shares of Evonik Industries in a research report on Wednesday, August 7th. JPMorgan Chase & Co. set a €26.00 ($30.23) price objective on shares of Evonik Industries and gave the stock a neutral rating in a research report on Thursday, August 1st. Finally, Barclays set a €27.00 ($31.40) price objective on shares of Evonik Industries and gave the stock a neutral rating in a research report on Monday, August 5th. Four research analysts have rated the stock with a sell rating, eight have given a hold rating and ten have assigned a buy rating to the company’s stock. Evonik Industries presently has a consensus rating of Hold and an average price target of €30.05 ($34.94).
FRA:EVK opened at €21.23 ($24.69) on Tuesday. Evonik Industries has a one year low of €26.78 ($31.14) and a one year high of €32.97 ($38.34). The firm’s fifty day moving average is €24.87 and its two-hundred day moving average is €25.14.
Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemicals, quaternary derivatives, polyurethane additives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, and animal nutrition and healthcare products.
Featured Story: Understanding Price to Earnings Ratio (PE)
Receive News & Ratings for Evonik Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evonik Industries and related companies with MarketBeat.com's FREE daily email newsletter.